In this episode, we explore the revolutionary potential of daridorexant, a new dual orexin receptor antagonist (DORA) for treating chronic insomnia. We discuss its unique mechanism of action, efficacy, and implications for future insomnia treatment. Could this medication be the key to "turning off" wakefulness in stubborn cases of insomnia?

Faculty: Carlos H. Schenck, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: Quick Take Vol. 58
• Use of Daridorexant for the Management of Chronic Insomnia

In this episode, we explore the risks and benefits of using lithium during pregnancy for women with bipolar disorder. We discuss recent research on cardiac malformations and dose-dependent risks. Is the fear of lithium use in pregnancy justified by the latest evidence?

Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1 CME: Perinatal Treatment of Bipolar Disorder
• Risks of Using Lithium in Pregnancy

In this episode, we explore a groundbreaking study on escitalopram's efficacy in treating generalized anxiety disorder in children and adolescents. We discuss its potential as the first FDA-approved medication for youth anxiety. How might this change our approach to pediatric anxiety treatment?

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 18
• The Role of Escitalopram in Treating Generalized Anxiety Disorder in Youth

In this episode, we explore psychodynamic psychopharmacology and its role in addressing treatment-resistant cases. We discuss how patient-doctor relationships, transference, and countertransference can impact medication effectiveness. How might your own unconscious biases influence your prescribing decisions?

Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships
• Cultivating a Therapeutic Alliance

In this episode, we explore the therapeutic potential of psychedelic compounds in psychiatry. We discuss their definition, mechanism of action, and potential uses in treating anxiety and depression. How might psychedelics reshape the future of psychopharmacology?

Faculty: Sidney LeFay, D.O. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: Quick Take Vol. 58
• Psychedelics as Transformative Therapeutics

In this episode, we explore the concept of patient ambivalence in psychopharmacology. How can understanding a patient's conflicting feelings about treatment improve outcomes? We discuss strategies for recognizing and addressing ambivalence, and its impact on medication adherence and effectiveness.

Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships
• Attending the Patient’s Ambivalence

In this episode, we explore vaping cessation methods used by US adolescent e-cigarette users. We discuss a study analyzing the prevalence and effectiveness of various quitting strategies, considering factors like demographics and perception of harm. How can healthcare providers tailor their approach to help teens quit vaping?

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 17
• Adoption of Vaping Cessation Methods by U.S. Adolescents

In this episode, we explore Psychodynamic Psychopharmacology, an innovative approach to treating medication-resistant patients. We discuss how psychological factors influence drug responses and learn techniques to enhance treatment outcomes. Could understanding the meaning patients attach to their medications be the key to unlocking treatment resistance?

Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships
• An Introduction to Psychodynamic Psychopharmacology

In this episode, we explore the complex relationship between benzodiazepine use and suicide risk, examining a groundbreaking French study that challenges our understanding of this connection. Is our go-to anxiety treatment potentially increasing suicide risk?

Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: Quick Take Vol. 57
• Risk for Suicide Attempts and Suicide Associated With Benzodiazepines

In this episode, we explore how a psychodynamic approach can shed light on treatment-resistant cases. Can understanding a patient's psychological dynamics be the key to unlocking better outcomes?

Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships
• Understanding the Problem of Treatment Resistance